title: Case Study Interpretation--Houston: Case 1. Phenytoin-induced ‘‘pseudolymphoma’’.
authors.affiliation: Washington University Medical Center, Department of Pathology and Immunology, St. Louis, Missouri 63110, USA. fkreisel@path.wustl.edu
authors.forename: Friederike
authors.initials: F
authors.lastname: Kreisel
mesh_terms: D000927:Anticonvulsants / Q000009:adverse effects* / Q000097:blood / Q000627:therapeutic use; D015703:Antigens, CD / Q000378:metabolism; D006801:Humans; D008297:Male; D008875:Middle Aged; D010672:Phenytoin / Q000009:adverse effects* / Q000097:blood / Q000627:therapeutic use; D019310:Pseudolymphoma / Q000097:blood / Q000139:chemically induced* / Q000175:diagnosis / Q000473:pathology; D016692:Receptors, Antigen, T-Cell, gamma-delta / Q000378:metabolism; D012640:Seizures / Q000188:drug therapy; D013601:T-Lymphocytes / Q000378:metabolism / Q000473:pathology
chemical_list: D000927:Anticonvulsants; D015703:Antigens, CD; D016692:Receptors, Antigen, T-Cell, gamma-delta; D010672:Phenytoin